Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners

International Clinical Psychopharmacology

Volumn 18, Issue 6, 2003, Pages 347-354

  Åkerblad, Ann Charlotte ^a   Bengtsson, Finn ^b   Ekselius, Lisa ^a   Von Knorring, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adherence; Compliance; Depression; Response; RHYTHMS; Sertraline; SSRI; TDM

Indexed keywords

ANTIDEPRESSANT AGENT; NORSERTRALINE; SERTRALINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; GENERAL PRACTITIONER; HEALTH PROGRAM; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DATA COLLECTION; DEPRESSIVE DISORDER; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; SERTRALINE; SWEDEN;

EID: 0842309251     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200311000-00006     Document Type: Article

References (25)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, DC: APA.
2. Björk H, Bengtsson F (1997). A simple method for routine TDM of the SSRI sertraline and desmethylsertraline in serum by HPLC. Eur Neuropsychopharmacol 138 (suppl 2):138.
3. Buckley P, Cannon M, Larkin C (1991). Abuse of neuroleptic drugs. Br J Addict 86:789-790.
4. Demyttenaere K, Mesters P, Boulanger B, Dewe W, Delsemme MH, Gregoire J, et al. (2001). Adherence to treatment regimen in depressed patients treated with amitryptyline or fluoxetine. J Affect Disord 65: 243-252.
5. Frank E, Perel JM, Mallinger AG, Thase ME, Kupfer DJ (1992). Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression. Psychopharmacol Bull 28:231-235.
6. George CF, Peveler RC, Heiliger S, Thompson C (2000). Compliance with tricyclic antidepressants: the value of four different methods of assesment. Br J Clin Pharmacol 50:166-171.
7. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology Revised. Rockville, MD: National Institute for Mental Health, Psychopharmacology Research Branch, pp. 217-222.
8. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, et al. (1995). Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 273:1026-1031.
9. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. (1996). A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 53:924-932.
10. Katon W, Von Korff M, Lin E, Simon G, Walker E, Unützer J, et al. (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression. Arch Gen Psychiatry 56:1109-1115.
11. Katon W, Rutter C, Ludman EJ, Von Korff M, Lin E, Simon G, et al. (2001). A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 58:241-247.
12. Keller MB, Hirschfeld RMA, Demyttenaere K, Baldwin DS (2002). Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 17:265-271.
13. Kutcher S, Leblanc J, Maclaren C, Hadrava V (2002). A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Prog Neuropsychopharmacol Biol Psychiatry 26:591-596.
14. Lingam R, Scott J (2002). Review article. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105:164-172.
15. Lundmark J, Reis M, Bengtsson F (2000). Therapeutic drug monitoring of sertraline: variability factor as displayed in a clinical setting. Ther Drug Monit 22:446-454.
16. McDonald HP, Garg AX, Haynes RB (2002). Interventions to enhance patient adherence to medication prescriptions. Scientific review. JAMA 288: 2868-2879.
17. Montgomery S, Åsberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
18. Montgomery SA, Kasper S (1995). Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 9 (suppl 4):33-40.
19. Mundt JC, Clarke GN, Burroughs D, Brenneman DO, Griest JH (2001). Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education. Depress Anxiety 13:1-10.
20. Paes AHP, Bakker A, Soe-Agnie CJ (1998). Measurement of patient compliance. Pharm World Sci 20:73-77.
21. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C (2002). Patient adherence in the treatment of depression. Br J Psychiatry 180:104-109.
22. Peveler R, George C, Kinnmonth AL, Campell M, Thompson C (1999). Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 319: 612-615.
23. Robinson GL, Gilbertson AD, Litwack L (1986). The effects of psychiatric patient education to medication program on post discharge compliance. Psychiatr Q 58:113-118.
24. Youssef FA (1983). Compliance with therapeutic regimens: a follow up study for patients with affective disorders. J Adv Nursing 8:513-517.
25. Wright EC (1993). Non-compliance or how many aunts has Mathilda? Lancet 342:909-913.